AMRS - .58 BZ: UPDATE: Amyris Says Biossance Product Sales Growth Expected to More Than Double vs What Was Originally Planned for '17 http://stockcharts.com/c-sc/sc?s=AMRS&p=D&b=5&g=0&i=t78977547781&r=1492085942765 http://stockcharts.com/c-sc/sc?s=AMRS&p=W&b=5&g=0&i=t83659522929&r=1492085915115